Steve Mertens insider trades
Open-market stock purchases and sales by Steve Mertens, Chief Technology Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, from SEC Form 4 filings since May 13, 2019.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 28, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Bought (not open market) | — |
| Mar 31, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Sold (not open market) | $704 |
| Feb 18, 2026 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Sold (not open market) | $5K |
| Dec 31, 2025 | NMTC NEUROONE MEDICAL TECHNOLOGIES Corp | Sold (not open market) | $687 |
Companies traded
- NMTC NEUROONE MEDICAL TECHNOLOGIES Corp: other filings, last Aug 28, 2026